General Chapter <821> Radioactivity
Total Page:16
File Type:pdf, Size:1020Kb
BRIEFING 821 Radioactivity, USP 38 page 616. This chapter was introduced in its current form in 1975 and has not undergone any major revision since its first publication. Currently, ⟨the chapter⟩ contains definitions, special considerations, and procedures with respect to the monographs for radiopharmaceuticals (radioactive drugs). The majority of this chapter is informational. USP has launched an initiative to minimize nonprocedural information in general chapters with numbers below 1000. The USP Council of Experts believes that 821 should be revised as part of this initiative. To achieve this objective, several members of the USP Council of Experts jointly published a Stimuli article in PF 38(4) [July–Aug.⟨ 2012],⟩ Revision of General Chapter Radioactivity 821 . The objectives of this Stimuli article were threefold: (1) provide background information about the need for the proposed revision, (2) initiate discussion about this topic, and⟨ (3)⟩ solicit public comments for review and discussion by the relevant Expert Committee and Expert Panel members and USP staff. The current chapter is divided into two major sections, General Considerations and Identification and Assay of Radionuclides, both of which contain several subsections with information about aspects of radioactivity. Because of the nature of the information presented in these subsections, these can be moved to the proposed Radioactivity— Theory and Practice 1821 . The Terms and Definitions section is now listed as Glossary and has been revised to reflect current practices. The revised chapter will contain procedures and⟨ information⟩ about instrumentation used in the identification and assay of the radionuclides, along with appropriate information about calibration and maintenance of instrumentation. To make the chapter more useful, we propose to include quantitative requirements such as minimum resolution for the detector, allowed variation for instrument performance, and appropriate interval for performance checks, as well as other useful parameters that can ensure the suitability of the equipment for its intended use. Interested parties are invited to submit their comments to the proposed revisions of the chapter. Additionally, minor editorial changes have been made to update the chapter to current USP style. (GCPA: R. Ravichandran.) Correspondence Number—C152699 821 RADIOACTIVITY Change to read: Radioactive pharmaceuticals require specialized techniques in their handling and testing in order that correct⟨ results⟩ may be obtained and hazards to personnel be minimized. All operations should be carried out or supervised by personnel having had expert training in handling radioactive materials. The facilities for the production, use, and storage of radioactive pharmaceuticals are generally subject to licensing by the federal Nuclear Regulatory Commission, although in certain cases this authority has been delegated to state agencies. The federal Department of Transportation regulates the conditions of shipment of radioactive materials. State and local agencies often have additional special regulations. Each producer or user must be thoroughly cognizant of the applicable regulations of the federal Food, Drug, and Cosmetic Act, and any additional requirements of the U. S. Public Health Service and of state and local agencies pertaining to the articles concerned. Definitions, special considerations, and procedures with respect to the Pharmacopeial monographs on radioactive drugs are set forth in this chapter. GENERAL CONSIDERATIONS Fundamental Decay Law The decay of a radioactive source is described by the equation: −λt Nt = Noe in which Nt is the number of atoms of a radioactive substance at elapsed time t, No is the number of those atoms when t = 0, and λ is the transformation or decay constant, which has a characteristic value for each radionuclide. The half-life, T1/2, is the time interval required for a given activity of a radionuclide to decay to one-half of its initial value, and is related to the decay constant by the equation: T1/2 = 0.69315/λ The activity of a radioactive source (A) is related to the number of radioactive atoms present by the equation: A = λN from which the number of radioactive atoms at time t can be computed, and hence the mass of the radioactive material can be determined. The activity of a pure radioactive substance as a function of time can be obtained from the exponential equation or from decay tables, or by graphical means based on the half- life (see Normalized Decay Chart, Figure 1). The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location. Fig. 1. Normalized Decay Chart. The activity of a radioactive material is expressed as the number of nuclear transformations per unit time. The fundamental unit of radioactivity, the curie (Ci), is defined as 3.700 × 1010 nuclear transformations per second. The millicurie (mCi) and microcurie (µCi) are commonly used subunits. The “number of nuclear transformations per unit time” is the sum of rates of decay from all competing modes of disintegration of the parent nuclide. Before the activity of any given radionuclide in a measured specimen can be expressed in curies, it is often necessary to know the abundance(s) of the emitted radiation(s) measured. Geometry The validity of relative calibration and measurement of radionuclides is dependent upon the reproducibility of the relationship of the source to the detector and its surroundings. Appropriate allowance must be made for source configuration. Background Cosmic rays, radioactivity present in the detector and shielding materials, and radiation from nearby radioactive sources not properly shielded from the measuring equipment, all contribute to the background count rate. All radioactivity measurements must be corrected by subtracting the background count rate from the gross count rate in the test specimen. Statistics of Counting Since the process of radioactive decay is a random phenomenon, the events being counted form a random sequence in time. Therefore, counting for any finite time can yield only an estimate of the true counting rate. The precision of this estimate, being subject to statistical fluctuations, is dependent upon the number of counts accumulated in a given measurement and can be expressed in terms of the standard deviation σ. An estimate for σ is √n where n is the number of counts accumulated in a given measurement. The probability of a single measurement falling within ±100/√n% of the mean of a great many measurements is 0.68. That is, if many measurements of n counts each were to be made, approximately two-thirds of the observations would lie within ±100/√n% of the mean, and the remainder outside. Because of the statistical nature of radioactive decay, repeated counting of an undisturbed source in a counting assembly will yield count-rate values in accordance with the frequency of a normal distribution. Deviations in these values from the normal distribution conform to the χ2 test. For this reason, the χ2 test is frequently applied to determine the performance and correct operation of a counting assembly. In the selection of instruments and conditions for assay of radioactive sources, the figure of merit ε2/B should be maximized (where ε = counter efficiency = observed count rate/sample disintegration rate, and B = background count rate). Counting Losses The minimum time interval that is required for the counter to resolve two consecutive signal pulses is known as the dead time. The dead time varies typically from the order of microseconds for proportional and scintillation counters, to hundreds of microseconds for Geiger-Müller counters. Nuclear events occurring within the dead time of the counter will not be registered. To obtain the corrected count rate, R, from the observed count rate, r, it is necessary to use the formula: R = r/(1 − rτ) in which τ is the dead time. The foregoing correction formula assumes a nonextendable dead time. Thus, for general validity, the value of rτ should not exceed 0.1. The observed count rate, r, refers to the gross specimen count rate and is not to be corrected for background before use in the foregoing equation. Calibration Standards Perform all radioactivity assays using measurement systems calibrated with appropriately certified radioactivity standards. Such calibration standards may be purchased either direct from the National Institute of Standards and Technology or from other sources that have established traceability to the National Institute of Standards and Technology through participation in a program of inter-comparative measurements. Where such calibration standards are unavailable, the Pharmacopeia provides the nuclear decay data required for calibration. These data, as well as half-life values, are obtained from the Evaluated Nuclear Structure Data File of the Oak Ridge Nuclear Data Project, and reflect the most recent values at the time of publication. Carrier The total mass of radioactive atoms or molecules in any given radioactive source is directly proportional to the activity of the radionuclide for a given half-life, and the amount present in radiopharmaceuticals is usually too small to be measured by ordinary chemical or physical methods. For example, the mass of 131I having an activity of 100 mCi is 8 × 10−7 g. Since such small amounts of material behave chemically in an anomalous manner, carriers in the form of nonradioactive isotopes of the same radionuclide may be added